Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

VolitionRx and Hologic Enter Co-Marketing Agreement for Nu.Q® Discover Services.

Sep 29, 2025•9 months ago

Contract Type

agreement

HendersonBiotechnologyHealth CareGeneticsTherapeutics

Description

VolitionRx Limited has signed a co-marketing agreement with Hologic for the promotion of its Nu.Q® Discover service. This partnership aims to expand customer access to innovative epigenetic profiling tools, with the potential for Hologic to become an exclusive provider of these services if successful.

Company Information

Company

VolitionRx

Location

Henderson, Nevada, United States

About

VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for VolitionRx's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months